Alteplase was first approved by the FDA in 1996 for acute ischemic ... Tenecteplase is also approved as a thrombolytic agent for patients presenting with acute MI. Recent studies have explored the ...

Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness ...

The activity and sterility of reconstituted alteplase solution and the effectiveness of an alteplase dose-escalation protocol for the clearance of midlinecatheter and central-venous-access device ...

The usage of tenecteplase in patients with acute ischemic stroke was associated with similar effectiveness and safety ...

The researchers observed no significant differences between tenecteplase and alteplase in terms of effectiveness or safety outcomes for the overall cohort after adjustment for covariates.